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Determining N7-Alkylguanine Adducts by
Immunochemical Methods and HPLC
with Electrochemical Detection: Applica-
tions in Animal Studies and in Monitoring
Human Exposure to Alkylating Agents
by Joost H. M. van Delft,' Monic J. M. van Winden,'
Angela M. C. van den Ende,' and Robert A. Baan'
Many xenobioticsexerttheirtoxiceffects through interaction withDNAinthecellsoftheexposedorganism. This in-
teractionmayleadtotheformationDNAadducts. Someofthesemaygiverisetomutationsthatinitiatecelltransforma-
tionand, ultimately, theformationoftumors. Sensitivemethodsfordetermining DNAadductsareindispensable forthe
study ofchemicalmutagenesisandcarcinogenesisandforbiomonitoring hunanexposuretogenotoxic agents. Alkylating
agentsformanimportantclassofgenotoxic compounds. They reactpreferentiallyattheN7-positionofguanine. Under
neutral or acidic conditions, the adducts can be readily released from the DNA backbone as the free base N7-
alkylguanine (N7-AlkGua). The imidazole ringofN7-alkyldeoxyguanosine (N7-AlkdGuo) can beopenedunderalkaline
conditions, whichresultsinformationofamorestableadductinDNA. Todevdopimmunochemicalmethodsforthedetec-
tionofN7-alkylations, weimmunized micewithvariousalkylguanosines inthering-opened form (RON7-AlkdGuo). An-
tibodies wereselectedtodetectadductsinisolatedDNAbycompetitiveELSAandinsinglecellsbyimmunofluorescence
microscopy (IFM). Variousmonoclonalantibodies werecharacterizedindetailwithrespecttospecificity andsensitivi-
ty towardmethylated, ethylated, andhydroxyethylatedDNAs. Theantibodiesshowedextensivecross-reactivity toward
N7-(m)ethyl- andN7-(2-hydroxyethyl)guanine modifications inthering-opened form. Thelimnitsofdetection inthedirect
andcompetitiveELISAwere5-10and 1-2adductsper10'nucleotides,respectively. ThedetectionlimitoftheIFMmethod
was about 20 adducts per 10' nucleotides. To calibrate the immunochemical methods, we used an HPLC with elec-
trochemical detection(HPLC-EC) toquantifyN7-methyl-,N7-ethyl-, andN7-(2-hydroxyethyl)guaninereleasedfromDNA
by neutral thermal hydrolyas. Thebaseadductswereseparatedfromnonmodifledguanineandadenineonareverse-phase
HPLCcolunm andquantifiedbyuseofanEC-detectoratanoaddationpotentialof1.35V. Foreachofthealkylatedguanines
mentioned, thedetection limit wasabout0.3adductsper10'nucleotides. Resultsarepresentedoftheapplicationofthe
immunochemical assaysandHPLC-EC toinvestigate theinduction ofmethylations in liverDNA ofratstreated in vivo
withlowdosagesofhydrazineandtheinductionofDNAmethylationsinnucleatedperipheralbloodcellscollectedfrom
a patient who receivedchemotherapy with themethylating cytostatic drug dacarbazine.
Introduction
It isgenerally acceptedthat mostchemicalcarcinogens initiate
neoplastic growthby interactionwiththegenetic material. DNA
modificationisthefirst step inthe processthat may finally lead
to mutation, cell transformation, and tumorigenesis (1). Al-
kylating agents, including N-alkylnitroso compounds, can be
regarded as an important group ofenvironmental and occupa-
tional carcinogens (2-4). These chemicals give rise to the
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transferofalkylgroups (methyl, ethyl, etc.)tonucleophilic sites
inDNA, preferentially totheN7-atomofguanine(5). Sensitive
methodsfordetectingandquantifyingtheresultingalkyl-DNA
adductsareindispensable formechanistic studiesofmutagenesis
and carcinogenesis induced by alkylating agents and for
biomonitoring humanpopulationswithanincreased riskforex-
posuretosuchgenotoxicants(6,7). Amongthevariousmethods
thatareavailablefordosimetryofgenotoxicdamagearephysico-
chemical andimmunochemical techniques (8,9).
This paper examines the development and validation ofim-
munochemical methods for detecting N7-alkylated guanines
withspecificmonoclonalantibodies. Asanindependentmethod
tocorroboratetheimmunochemicaldata, anHPLCmethodwas
developed with sensitive electrochemical detection of several
N7-alkylguanines. Bothmethods were setup formethyl (Me),VANDELFTETAL.
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FIGURE 1. Formation ofN7-alkylguanosine followed by ring-opening or depurination.
ethyl (Et), and2-hydroxyethyl (EtOH)adducts. Thelatteradduct
is formed on exposure of DNA to ethylene oxide. Results are
presented of the comparative immunochemical and elec-
trochemical analysis ofN7-methylguanineadducts inliverDNA
isolated from rats treated in vivo with hydrazine, an indirect
methylating agent. Preliminary results arepresentedoftheim-
munochemical analysis ofalkyl-DNAdamageinhumanblood
cells obtained during chemotherapy of a patient with the
alkylating cytostatic drug dacarbazine.
N7-alkylguanine (N7-AlkGua) is the most abundant form of
base damageinalkylated DNA (5). Formationofthis adductin-
volves the introductionofapositivechargeintheimidazolering
ofthepurine, which leadsto anunstablechemical structure. This
instability canberesolvedin oneoftwo ways. Theimidazolering
ofN7-AlkGua can beopened under alkaline conditions, which
results intheformation ofa morestableadductinDNA. Under
neutral oracidic conditions hydrolysis can occur, during which
N7-AlkGua is cleaved off(Fig. 1).
In the approach to immunochemical detection of N7-
alkyldeoxyguanosine (N7-AlkdGuo) inDNA, thenucleoside ad-
ducts in theirstablering-opened form wereused ashaptens toob-
tain the specific antibodies needed. Prior to immunochemical
detection, N7-alkylguanines inDNA wereconverted tothering-
opened form. Electrochemical detection ofDNAalkylation was
based on analysis ofthe free base adducts (N7-alkylguanines).
Materials and Methods
Preparation of N7-Alkylguanosines, N7-Alkyl-
guanines, and Alkylated DNA
N7-Ethylguanosine (N7-EtGuo) and N7-hydroxyethylguano-
sine (N7-EtOHGuo) were synthesized by treating guanosine
withN-ethyl-N-nitrosourea (ENU) andethyleneoxide (EtOx),
respectively. N7-methylguanosine (N7-MeGuo) waspurchased
fromSigma(St. Louis, MO). Afterpurificationofthenucleoside
adducts on asilicacolumn, one part wasconvertedintothe im-
idazolering-opened formby treatmentwithalkali, whileanother
part wasdepurinatedbyheating atneutralpH. Someofthering-
opened(RO)product wasalsodepurinated. TheproductsRON7-
AlkGuo, N7-AlkGua, and RON7-AlkGua were purified by
reverse-phase orcation-exchange HPLC. Thepurity ofseveral
products was verified by 'H-NMR spectroscopy and MS-MS
analysis (courtesy ofE. Marafante, JointResearchCentreofthe
European Community, Ispra).
DNAcontainingRON7-AlkGua waspreparedbyin vitrotreat-
mentofsalmon spermDNA withENU,N-methyl-N-nitrosourea
(MNU), orEtOx, followedbyalkali-inducedringopeningofthe
N7 adducts. Human white blood cells (WBC) with N7-alkyl-
DNAadducts wereobtainedby in vitro exposureofWBC from
a healthy donor to ENU or EtOx, followed by fixation in 70%
ethanol. Later on, duringthe immunochemical procedures, the
N7adducts weretransformed intothering-openedform [see van
Delft et al. (10) for experimental details].
Isolation and Selection ofAntibodies
Antibodies wereraised inmiceagainstthe ring-opened form
ofN7-EtGuo(RON7-EtGuo). Aseriesofmonoclonal antibodies
wereobtained, which werecharacterizedwith respectto cross-
reactivity with N7-methyl, N7-hydroxyethyl, and N7-sulfur
mustard adducts. Antibodies wereespecially selected forgood
performance in in situ detection ofDNA damage, by means of
a cell ELISA (10). In a second series of immunizations, an-
tibodies were raised against RON7-EtOHGuo. Suitable an-
tibodies (N7E-026 and N7E-102, raisedagainst RON7-EtGuo,
and N7EO-E, raised against RON7-EtOHGuo) were selected
andused todeterminethelevelofDNAalkylation insinglecells,
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FIGURE 2. Characterization of monoclonal antibodies raised against ring-opened N7-ethylguanosine (RON7-EtGuo) or 2-hydroxyethylguanosine
(RON7-EtOHGuo) by useofadirect ELISA. (A) Salmon sperm DNA was treated with various amountsofethyleneoxideandused ascoatingantigen. The an-
tibodies tested were N7E-102, raisedagainst RON7-EtGuo (0), andN7EO-E, raisedagainst RON7-EtOHGuo(0). (B) Salmonsperm DNA treatedwithvarious
amounts ofN-methyl-N-nitrosurea (+) orethylnitrosourea (0,-) was used ascoating antigen. The antibodies tested were N7E-026 (+,0) and N7E-102 (0),
both raised against RON7-EtGuo. Adduct levels inthecoating DNAs (abscissa) were determined by HPLC-EC. The fluorescence indicated on the ordinate is
a measure ofthe amountofantibodies boundtothe immobilized antigen (seeMaterials andMethods). Averages offourwellsarepresented [seevan Delftetal.
(10) fordetails].
Table 1.CompetitiveELISAofmonoclonalantibodiesagainstRON7-AlkGuo
with alkylated DNA.
Competitor DNA fmole N7-AlkGua at 50% inhibition for MAb
Alkylation Adduct levelb N7E-026 N7E-102 N7EO-E
Methyl 11 57 ND ND
60 66 ND ND
117 43 ND ND
Ethyl 11 150 ND ND
60 180 ND ND
259 130 ND ND
2-Hydroxyethyl 16 ND 310 89
57 ND 77 70
256 ND 28 52
Abbreviations: Mab, monoclonal antibody; RO, ring opened; N7-AlkGuo,
N7-alkylguanosine; N7-AlkGua, N7-alkylguanine; MNU, N-methyl-N-nitro-
sourea; DES, diethylsulfate; EtOx, ethylene oxide; EtGuo, ethylguanosine;
EtOH, 2-hydroxyethyl.
aExpressed as the amount in inhibitor in a well ofa microtiter plate that in-
duces50% inhibitionofthebindingoftheMAb(culturesupernatantdiluted6000-
to 30000-fold) to immobilized antigen [DNAtreated with MNU (1400 Me/106
nucleotides), DES (2600 Et/106 nucleotides), or EtOx (730 EtOH/106
nucleotides)]. Antibodies N7E-026 and N7E-102 were raised against
RON7-EtGuo; N7EO-EwasraisedagainstRON7-EtOHGuo. Forthethreean-
tibodiestested, the amountofunmodified DNArequiredfor50% inhibitionof
antibody binding varied between 5 x 10' and 2 x 10i fmolenucleotides.
bDetermined by HPLC-EC; values expressed as RON7-AlkGua per 106
nucleotides.
e.g., in human WBCs by immunofluorescence microscopy
(IFM)andinisolatedDNAby(competitive)ELISA. Thevarious
immunoassays arebrieflydescribed inthefollowingparagraphs.
Fullexperimentaldetailsoftheseprocedureshavebeenprevious-
ly published (10).
Immunochemical Methods
TheELISAisawell-known methodforquantifyingantigens.
Intheassayasappliedinthepresentwork, DNA(withorwithout
adducts) was used as immobilized antigen. The amount of
monoclonalanti-RON7-allylGuo antibodyboundtothecoating
antigen was determined by binding of an alkaline
phosphatase/goat-anti-mouse immunoglobulinconjugateand in-
cubationwithacolorigenicorfluorogenic substrate. Inthecom-
petitiveELISA, theamountofantigenisdeterminedthatcauses
50% inhibition of the binding of antibodies to immobilized
alkylatedDNA. Thisvalueisameasureoftherelativepreference
ofthe antibody forthe inhibitor.
Forthe IFM procedure, fixedWBC weredeposited on glass
slides, treatedwithalkalitoinducedenaturationofDNAandring
opening of N7-alkyl adducts, and incubated with anti-adduct
monoclonal antibody and goat-anti-mouse immunoglobulin-
fluorescein isothiocyanate (FITC) conjugate. With a scanning
laserfluorescencemicroscope andcomputerprocessing ofthe
emission signal, the amountofFITC fluorescence per nucleus
canbedetermined (11).
HPLC withElectrochemical Detection
A physicochemical method, HPLC with electrochemical
detection(HPLC-EC), wasdevelopedforthequantification of
the free base adducts N7-MeGua, N7-EtGua (12), and
N7-EtOHGua(13). Electrochemical detectionofcompounds is
basedonredoxreactions, whichoccurattheappropriateoxida-
tionpotential. Detection wasachievedbyuseofanamperometric
detector cell (Antec, Leiden, The Netherlands), containing a
glassycarbonworkingelectrodeandanAg/AgClreferenceelec-
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trode. Changes in electric current (in nA) through the cell are
recorded. TheamountofN7-AlkGua inDNA samples wasquan-
tified by comparing peak heights with those observed upon
analysis ofstandard samples. DNA samplesforHPLC-EC were
prepared as follows. N7-AlkGua was liberated from DNA by
neutral thermal hydrolysis, whereafter DNA was removed by
precipitation with HCl andcentrifugation. Thesupernatantwas
neutralized andanalysedbyHPLC-EC. Fullexperimental details
ofthe HPLC-EC method have been published elsewhere (13).
Isolation ofRat Liver DNA Samples
Rats (Wistar) were fastedovernightanddosedbygavagewith
various amounts ofhydrazine (0.01-10mg/kgbody weight). After
16hr, theanimals were sacrificedandthe livers were removed,
frozen, andpulverized (theseexperimentswereperformedbyJ.
LewalteratBayerwerke, Leverkusen, FRG). DNAisolationwas
performed inseveral steps, throughsequentialisolationofnuclei,
chromatin, and nucleic acids. RNA was then degraded by in-
cubations with RNAse A and TI. The absence of RNA was
checked by chromatographic determination of the amount of
3'-riboguanosine monophosphate in an enzymic DNA digest
(M.-J.S.T. Steenwinkel, manuscript inpreparation). Before im-
munochemical analysis, the DNA wasalkalitreated for30min
at 37°C to induce ring opening ofN7-methylguanine adducts.
Priortoelectrochemical analysis, theDNAwasincubatedfor30
min at 70°C, to release N7-MeGua.
Processing ofBlood Samples from Patients
Receiving Chemotherapy
Blood was collected from a patient who received chemo-
therapy with themethylating cytostaticdrugdacarbazine (DTIC;
5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide). The
dose, administered by infusion, was400mg/M2. Bloodsamples
weretakenatvarious timepoints following thetreatmentandim-
mediately cooled on ice. DNA was isolated, alkalitreated, and
analyzed for the presence of N7-MeGua adducts in a direct
ELISA [see van Delft et al. (10) for experimental details].
Results
Immunochemical Detection
Monoclonal antibodies were raised against RON7-EtGuo and
RON7-EtOHGuo. Theantibodies were selectedfortheir suita-
bility to recognize these adducts in DNA in situ by IFM and in
isolated DNAby ELISA. Severalantibodies werecharacterized
with respect to specificity, by investigation of their cross-
reactivity with other N7-alkyl adducts, and to sensitivity by
determinationofthedetection limits invarious immunochemical
assays (10,14). In addition to antibodies that recognize ethyl
and/or 2-hydroxyethyl adducts in the ring-opened form, a
suitable monoclonal antibody wasobtained forthedetectionof
methyl modifications (N7E-026). Here, dataarepresentedofan-
tibodies N7E-026 and N7E-102 (raised against RON7-EtGuo)
and N7EO-E (raised against RON7-EtOHGuo). Alkylation
levels in in vitro modified DNA weredetermined by means of
ELISA with the various antibodies. The results, presented in
Figure 2, show that ethyl, methyl, and 2-hydroxyethyl adducts
can be detected with about equal sensitivities. In all cases a
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FIGURE 3. Detection ofN7-ethylguanine (N7-EtGua) in the nuclei ofwhite
blood cells (WBC) by means ofimmunofluorescence microscopy with an-
tibody N7E-026 (-) and of 2-hydroxyethylguanine (N7-EtOHGua) with
N7EO-E(O). Thedose-response relationship wasestablished withperipheral
humanbloodcellsthathadbeentreated withethylnitrosoureaorethyleneox-
ide. DNA adduct levels in these cells were determined in purified WBC-
DNAby HPLC-EC. Nuclearfluorescence isameasureofthenumberofan-
tibodies bound to nuclearDNA percell. Averages with SDsofabout30cells
are presented.
dose-dependent increaseoftheresponsewasobservedforadduct
levels above 10 N7-alkylations per 106 nucleotides.
Thecompetitive ELISAcanbeusedtodeterminethe level of
N7-alkylation inanunknownDNAsamplebycomparisonofthe
responsewiththeinhibitioncurvesobtainedwith standard alkyl-
DNAsamples. Dataintheliterature indicatethatthebindingef-
ficiency ofantibodiestocompetitorDNAmay strongly depend
onthemodificationlevelofthis DNA(15,16). Experiments were
carried outtoinvestigatethe effectofthealkylation level ofthe
competitorDNAonthetotalamountofadductsrequiredfor50%
inhibitionofanti-alkyl-adductantibody-binding. Theresultsare
shown in Table 1. Adduct levels in methylated, ethylated, and
hydroxyethylated DNA (standard preparations) weredetermined
electrochemically (see below). These DNAs were then alkali
treatedandusedascompetitors inthecompetitiveELISA. The
50% inhibitionpoints weredetermined forthemonoclonal an-
tibodiesN7E-026(testedwithMe-andEt-DNA), N7E-102, and
N7EO-E (testedwithEtOH-DNA). Only inthecaseofantibody
N7E-102 wasastrongeffectofthemodificationlevelofthecom-
peting DNA observed.
The sensitivity of the in situ detection of N7-EtGua and
N7-EtOHGua in the nuclei of WBC was investigated by IFM
withmonoclonalantibodiesN7E-026andN7EO-E. Themicro-
scope images were computer processed to identify the nuclei,
and the nuclear immunofluorescence was quantified (11). A
linearrelationship wasobservedbetweennuclearfluorescence
and alkylation levels above 10 N7-EtGua and above 20 N7-
EtOHGua per 106nucleotides, respectively. Results are shown
in Figure 3.
HPLC with Electrochemical Detection
Inordertocalibratetheimmunochemical assays, quantifica-
tionofN7-methyl-, N7-ethyl-, orN7- (2-hydroxyethyl)-guanine
adducts inthevarious coating DNAs was carried outby means
of HPLC-EC. After neutral thermal hydrolysis of the DNA,
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FIGURE 4. HPLC-EC analysisofN7-ethylguanine (N7-EtGua) in DNA. Salmon sperm DNA wastreated with 1.25mM ethylnitrosourea (ENU) for 30 min at 37°C.
Afterdepurination and acid precipitation ofthe DNA, the supernatant was neutralized and run on reverse-phase HPLC. Electrochemical detection occurred at
an oxidation potential of 1.35 V. Analyses are shown ofauthentic N7-EtGua (left panel), 35 jig ENU-treated DNA (middle panel), and 80 ,kg control DNA that
had been processed in the same way (right panel). The positions ofthe guanine, adenine, and N7-EtGua peaks were identified by HPLC analysis with a diode-
array UV-detector and that ofthe N7-EtGua peak also by co-chromatography with authentic N7-EtGua.
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FIGURE 5. Determination ofN7-alkylguanine (N7-AlkGua) by HPLC-EC. (Left) Salmon sperm DNA was treated with various amounts ofN-methyl-N-nitrosourea
(0), ethylnitrosourea (ENU) (+) or ethylene oxide (EtOx) (0). After thermal hydrolysis at neutral pH and precipitation ofDNA, the liberated base adducts
(N7-AlkGua) were separated from othernucleobases by reverse-phase HPLCanddetected with theelectrochemical detector set at 1.35 V. Thebackground cur-
rent was 15-30 nA. Data aregiven as the average resultoftwoanalyses. The slopeofthelog/log plots is about 1.02. (Right) Whiteblood cells (WBC) from a healthy
donor were incubated at 37°C with various amounts ofENU (30min, +) orEtOx (15min, 0; 60min, 0). DNA was isolated fromthecells, whereafterN7-AlkGua
was liberated, purified, and analyzed as described above. Thedetection limitofthis HPLC-EC analysis is about0.3 AlkGua per 106 nucleotides in isolated DNA
(10,13).
N7-AlkGua was separated from other nucleobases by chrom-
atography on areverse-phase HPLC columnandanalyzed elec-
trochemically. A typical elution pattern obtained with ENU-
treated DNAis shown inFigure4. Thepeaks werequantified on
thebasis ofthesignalsobtained withknownamountsofauthentic
N7-AlkGua (Fig. 4, left panel).
Determinationofadducts in aseriesofDNAsamplesexposed
in vitro to analkylating agent(MNU, ENU orEtOx)alsoshowed
a linear dose-dependent increase in the level of N7 modi-
fications (Fig. 5, leftpanel). Similar results wereobtained upon
teatment of nucleated blood cells with ENU or EtOx, isola-
tion of DNA, and analysis of N7-alkylguanine (Fig. 5, right
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panel). Thedetection limitofthis HPLC-EC analysis forDNA
samples is about 0.3 N7-AlkGua per 106 nucleotides.
ApplicationsofELISAandHPLC-ECforAnalysis
ofDNAalkylation
AnalysisofN7-MethylguanineAdducts inLiverDNAofRats
TreatedwithHydrazine. Hydrazine, (NH2NH2), was shown to
induce methylations in DNAby an indirect mechanism, which
probably involves S-adenosyl-methionine (17). It belongs to a
groupofcompounds forwhichthereisevidencethatthein vivo
genotoxic effects becomemanifestonly upon exposure toacutely
toxic dose levels (18). Experiments were carried out to in-
vestigatewhetherthisphenomenon isreflected inthepatternof
dose-dependent DNA methylation after in vivo exposure ofrats
to various dosesofhydrazine. Sixteen hours after treatment with
a singleoral dose ofthecompound, theanimals were killed and
DNA was isolated asdescribed in Materials andMethods. Part
ofthe DNA wastreated with alkali to induce ringopeningofthe
N7-linkedguanineadducts. Thismaterial was furtheranalyzed
by competitive ELISA with antibody N7E-026, which shows a
strong (cross)reactivity with N7-MeGuo lesions in DNA.
Another partoftheDNA washeated atpH 1 and70°C for30min
to release N7-MeGua. After prepurification by cation-exchange
HPLC, thefractioncontaining thealkylguanine wasanalyzedby
reverse-phase HPLC-EC (the protocol for this prepurification
andanalysis waskindly providedby A. deGroot, State Univer-
sity, Leiden). Details of these experiments will be published
elsewhere (Van Delft et al., manuscript in preparation). The
combined results, presented in Figure6, show adose-dependent
increase in the level ofDNA methylation afterhydrazine doses
of 1 mg/kg orhigher. Furthermore, there appears to be aback-
ground level ofmethyl DNA adducts in untreated animals.
Analysis ofDNAMethylationInducedbyChemotherapeutic
Treatment. An interestingapplicationofthevariousmethods for
dosimetry ofDNA damage in humans in vivo is the analysis of
the effects ofiatrogenic exposure, i.e., duringchemotherapeutic
treatmentofpatients withgenotoxic cytostatic compounds (14).
We investigated the formation of methyl adducts in DNA of
peripheral blood cells obtained from a patient who received a
single doseofdacarbazine, an indirectly methylating cytostatic
drug. Immunochemical detectionofN7-MeGua in DNAisolated
fromthesecells wascarried outbydirectELISA, withantibody
N7E-026. Results are shown in Figure 7. During the first hour
after the end of the treatment, a rapid increase in the level of
methylation was observed, followed by a slow decrease during
the followingdays.
Discussion
This paper has presented the characterization of several
monoclonal antibodies directed againstvarious N7-alkylguano-
sines. During immunizationofthemice and screening ofthe an-
tibodies, thechemically stableimidazolering-openedformofthe
alkylated nucleosides was used (10; see Fig. 1). Theantibodies
were compared with respect to theirperformance in thedetec-
tion ofalkylations in isolated DNA, by direct andcompetitive
ELISA, and in situ, at the single-cell level by IFM. As an in-
dependent assay to confirm the immunochemical data, HPLC
with electrochemical detection (HPLC-EC) wasdeveloped for
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FIGURE 6. Formation ofN7-methylguanine (N7-MeGua) in liver DNA of rats
exposed tohydrazine. Ratsreceived asingledoseofhydrazineby gavage. The
animals were sacrificed 16 hr after the treatment. Liver DNA was isolated
and processed for immunochemical or electrochemical detection of
N7-methylguanine, asdescribed in Materialsand Methods. Bars represent
range of values of duplicate experiments from three or six rats at each
hydrazineconcentration. Thedetection limit, i.e., the responseobserved with
unmodified salmon spermDNA, was 1 N7-MeGua forthe ELISA, and0.4
N7-MeGua for the HPLC-EC method.
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FIGURE 7. Analysis of N7-methylguanosine (N7-MeGua) adducts in peri-
pheral blood cells of a patient who received400 mg/m2 decarbazine by IV
infusionduring 30 min. The firstblood sample was collected 1 hrafterthe
endofthe infusionperiod. TheanalysisofN7-MeGua in DNA wascarried
out in a direct ELISA as described in Materials and Methods. The signal
observed with the sample takenbefore the start ofthe treatment, indicated
by -1 ontheabscissa, wasbelowthe limitofdetection (1.2 N7-MeGua per
106 nucleotides; dashed line).
various N7-alkylguanines, releasedfromDNA asfreebasead-
ducts by neutral thermal hydrolysis.
Forthreeoftheantibodiesobtained, thespecificities and sen-
sitivitiestowarddifferentring-openedN7-alkylguanine adducts
wereinvestigatedindetail(14). Oneoftheanti-RON7-EtGuo an-
tibodies (N7E-026)appearedtobesuitablefordetectingmethyl
adducts, while another (N7E-102) recognized hydroxyethyl
modifications evenbetterthanethyladducts. Inthis respectthe
latter antibody was comparable to that raised directly against
RON7-EtOHGuo (N7EO-E; compare the results ofthe direct
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ELISA, Fig. 2). Thesedataindicatethatthecombinationofthese
antibodies may beuseful foranalyzing DNA samples thatcon-
tain various N7-alkylguanine lesions. Such a situation may oc-
cur in practical applications, e.g., in biomonitoring studies of
human populations exposed to a mixture of uncharacterized
alkylating chemicals. Combinationofassayswithdifferentan-
tibodiesmaygivemoreinformation, forinstance, withN7E-026
about the total ofmethyl and ethyl adducts and with N7EO-E
more specificallyabout hydroxyethyl guanine.
The sensitivities ofthedifferent immunochemical assays ap-
peared tovary substantially. A5-to 10-folddifference was seen
inthetwoELISAs. InthedirectELISAthelimitofdetectionwas
10 N7-methyl- orN7-ethyl-, and 5-10N7-hydroxyethylguanine
adducts per 106nucleotides, forantibodiesN7E-026andN7EO-
E, respectively (see Fig. 2). The competitive ELISA with
alkylated DNA as inhibitor was the most sensitive method, al-
lowing thedetectionof 1-2 N7-alkylguanines per 106nucleotides
[datanotshown, comparevanDelftetal. (10)]. Thislimitis set
by the binding ofthe antibody to untreated DNA. This binding
is nonspecific and not indicative of a real alkylation level,
becausethemaximum amountsofN7-EtGuaandN7-MeGuain
this DNA, asdeterminedbyHPLC-EC, are0.15 and0.36alkyla-
tionsper 106nucleotides, respectively (Fig. 6). ThedirectELISA
is less sensitivethanthecompetitive ELISA, butithasthegreat
advantage thatmuch smalleramountsofDNA(1 versus 100 .tg)
are required and thatthe assay takes less time. Theanalysis by
immunofluorescence microscopy showedthehighestdetection
limit of the methods applied, viz. = 20 N7-EtGua per 106
nucleotides (Fig. 3). It is notunusual forassays such as ELISA
to be one or two orders ofmagnitude more sensitive than im-
munocytochemical techniques. The latter assays, however, offer
theuniqueopportunity toanalyzeDNAmodifications atthelevel
ofthe single cell.
HPLC-ECproved to beasimpleandsensitivemethod forthe
detection ofN7-alkylguanines. It permits a quantitative deter-
minationoftheseadductsoverawideconcentration range. The
detection limitoftheHPLC-EC analysis is inmostcasesdeter-
mined by asmall electrochemical signal inthe HPLCpatternof
untreated DNA at the expected elution position of the N7-
alkylguanine. InFigure4(rightpanel), theresponsewouldcor-
respond toabout0.3 N7-EtGuaper 106nucleotides. Itisunclear,
however, whether this signal really represents N7-EtGua or an
unknown component.
Because ofits strongcross-reactivity with RON7-MeGuo, an-
tibody N7E-026 wasusedfortheanalysisofmethylations inliver
DNAofratsexposedtoasingledoseofhydrazine, acompound
showntoinducemethylationsofDNAbyanindirectmechanism
(17). Evidence has been presented that hydrazine can be con-
sidered agenotoxic andcarcinogenic compound, butprobably
only atacutely toxicdoselevels (18). Toinvestigatewhetherthis
phenomenon is reflected inthepatternofadductinduction, liver
DNA ofhydrazine-treated rats wasanalyzed forthepresenceof
methyl adducts, with the immunoassay and HPLC-EC. The
preliminary results of these experiments, shown in Figure 6,
demonstrate agoodcorrelationbetweenthetwomethods. Onthe
basis ofthe low detectionlimitoftheHPLC-EC technique, the
conclusion canbedrawnthatacertainlevelofDNAmethylation
is already present in untreated rats. This would confirm data
presentedbyotherauthors (19). Amoredetailed accountofthese
experiments and a discussion of the results will be published
elsewhere (van Delft et al., manuscript in preparation).
The antibody N7E-026 also appears suitable for analyzing
methyl-DNA adduct formation and removal in vivo, as was
shownwithperipheral bloodcellsofapatientreceiving chemo-
therapy with the methylating cytostatic drug dacarbazine (see
Fig. 7). These experiments are part of a study on the in vivo
kineticsoftheformation andpersistenceofmethyl-DNAadducts
in man. In this study, both N7-methyl- and 06-methyl adduct
levels in human lymphocytes and granulocytes will be in-
vestigated in relation to the capacities of these cells to meta-
bolically activate the methylating genotoxicant and to repair
methyl-DNA lesions.
The methods reported in this paper for the detection of
N7-EtOHGua may also be applied for the quantification of
N7-(2-oxoethyl)guanine (N7-EtOGua), asthisbasemodification
canbetransformed quantitatively into N7-EtOHGua by reduc-
tion with sodiumborohydride. N7-EtOGua is thepredominant
DNA lesion induced in vivo by many chemicals, such as vinyl
chloride, urethane, and othercompounds.
The determination of N7-AlkGua by means of the assays
described heremay beauseful tool tostudy therelationshipbe-
tweenthe induction and repairofdamages in cellular DNA on
theonehand, andtheresultingbiological effects, e.g., cytogen-
etic aberrations, mutagenesis andcarcinogenesis, ontheother.
Furthermore, these techniques can be of value for assessing
human exposure to occupational and environmental genotox-
icants, e.g., nitrosamines, EtOx, vinylchloride, andothercom-
pounds, byanalysis ofbloodorurine samples. Thechoiceofan
analysis methoddepends ontherequirements, suchassensitivity
anddetection in situ or in isolated DNA, and on the amount of
material that is available.
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